Northwire Canada EditionTuesday, August 25, 2026
Northwire
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
M&A / Property Neutral

Rocket Doctor Takes Center Stage in Inaugural NASCAR Cup Series Race at Naval Base Coronado as Primary Partner of Rick Ware Racing

AI-driven telehealth platform scaling U.S. payer network, but burning cash and diluting equity to fund marketing.

Executive Summary
  • Rocket Doctor AI announced a multi-event motorsports marketing partnership with Rick Ware Racing and FinTekk AP.
  • The company will serve as the primary sponsor of the No. 51 Chevrolet in the NASCAR Cup Series, launching at the inaugural Anduril 250 at Naval Base Coronado.
  • The campaign includes approximately 50 planned activations across 2026, targeting veterans, rural residents, and underserved demographics.
  • Consideration for the marketing services is structured entirely in equity: up to 10,000,000 common shares valued at $0.50/share ($5.0M USD) for 2026 services, with a 2027 renewal option for an additional $5.0M in shares.
  • Shares will be issued in monthly installments starting July 2026, subject to a 12-month contractual lock-up per tranche.
Material Impact
  • The partnership is a standard customer acquisition and brand awareness play, aligning with the company's stated focus on reaching underserved and rural U.S. populations.
  • The equity-based consideration structure is the critical factor. Instead of consuming cash, the company is issuing new shares to pay for marketing. This introduces immediate and future dilution to existing shareholders.
  • The deal does not alter the fundamental revenue trajectory, profitability, or cash flow profile. It is an incremental operational update that reflects management's continued push for U.S. market penetration.
  • Given the company's tight liquidity and negative cash flow, paying for marketing in shares rather than cash is a capital allocation choice that prioritizes balance sheet preservation over shareholder equity retention.
AIDR · Price
Company Overview
  • Rocket Doctor AI operates an AI-powered digital health platform providing telemedicine, clinical decision support, and mental health services.
  • The company has expanded its U.S. in-network reach to over 21 million insured members across California, New York, and Maryland.
  • Strategic focus includes serving veterans, rural communities, and underserved populations through physician-led virtual and hybrid care.
  • The platform integrates a proprietary Global Library of Medicine (GLM) for clinical decision support and has pursued strategic acquisitions (e.g., Alea Health) and partnerships to enhance AI capabilities.
Read the original news release →

More from Rocket Doctor AI Inc.